Images

Filter by

Treatment Strategy and Suggested Algorithm Depending on CS Stages
Treatment Strategy and Suggested Algorithm Depending on CS Stages
Comparison of Temporary Mechanical Circulatory Support Systems
Comparison of Temporary Mechanical Circulatory Support Systems
Figure 1 Pathophysiological Changes in Patients with Heart Failure Highlighting the Haemodynamic Alterations and Neuroendocrine Activation as well as the Pharmacological Targets
Figure 1: Pathophysiological Changes in Patients with Heart Failure, Highlighting the Haemodynamic Alterations and Neuroendocrine Activation as well as the Pharmacological Targets
Figure 2 Simplified Flowchart of the Pharmacological Treatment of Patients with Systolic Heart Failure
Figure 2: Simplified Flowchart of the Pharmacological Treatment of Patients with Systolic Heart Failure
Pharmacological Pathways and Indications of the New Medical Treatments
Pharmacological Pathways and Indications of the New Medical Treatments
The Four Domains of Sodium–Glucose Cotransporter Type 2 Inhibitors
The Four Domains of Sodium–Glucose Cotransporter Type 2 Inhibitors
Women’s Benefit in RCTs Dedicated to HF for SGLT2is
Women’s Benefit in RCTs Dedicated to HF for SGLT2is
Comparison of Different Populations Enrolled and of Different Outcomes in Major RCTs in Chronic HFREF
Comparison of Different Populations Enrolled and of Different Outcomes in Major RCTs in Chronic HFREF
Women’s Benefit in Randomised Controlled Trials Dedicated to Prevention for Different Class of Drugs
Women’s Benefit in Randomised Controlled Trials Dedicated to Prevention for Different Class of Drugs
Key Performance Indicators for Shock Centers of Excellence
Key Performance Indicators for Shock Centers of Excellence
Criteria for the Ideal Cardiogenic Shock Network
Criteria for the Ideal Cardiogenic Shock Network
Definitions of Key Components of a Network based Approach for Cardiogenic Shock
Definitions of Key Components of a Network-based Approach for Cardiogenic Shock